Pactiv Evergreen’s Strategic Transition: Hold Rating Amid …

3 days ago · Robert W. Baird analyst Ghansham Panjabi maintained a Hold rating on Pactiv Evergreen (PTVE – Research Report) yesterday and set a price target of $12.00. Ghansham …

CouponFollow Extension

$12.00
OFF

Pactiv Evergreen’s Strategic Transition: Hold Rating Amid …

1 week from now

3 days ago · Robert W. Baird analyst Ghansham Panjabi maintained a Hold rating on Pactiv Evergreen (PTVE – Research Report) yesterday and set a price target of $12.00. Ghansham …

businessinsider.com

$15.00
OFF

Jefferies Remains A Buy On Pactiv Evergreen (PTVE)

1 week from now

3 days ago · Jefferies analyst Philip Ng maintained a Buy rating on Pactiv Evergreen (PTVE – Research Report) today and set a price target of $15.00. The company’s shares closed …

businessinsider.com

$14.57
OFF

Pactiv Evergreen (PTVE) Stock Forecast And Price Target 2024

1 week from now

4 days ago · Consensus Price Target. According to the 7 analysts' twelve-month price targets for Pactiv Evergreen, the average price target is $14.57. The highest price target for PTVE is …

marketbeat.com

$83
OFF

Mill Divestiture ‘marks An Important Milestone’ For Pactiv Evergreen

1 week from now

5 days ago · Pine Bluff sale: Pactiv Evergreen completed the $83 million divestiture of its mill in Pine Bluff, Arkansas, and another in Waynesville, North Carolina, to Suzano on Oct. 1. Pactiv …

packagingdive.com

$1
OFF

Earnings Call: Pactiv Evergreen Reports Strong Q3 2024 Results Amid ...

1 week from now

Pactiv Evergreen reported Q3 2024 revenues of $1.3 billion and adjusted EBITDA of $214 million. The company finalized the sale of its mill operations, moving towards a capital-light business …

investing.com

$13.00
OFF

Pactiv Evergreen (PTVE) Receives A Buy From RBC Capital

1 week from now

Oct 17, 2024 · In a report released yesterday, Arun Viswanathan from RBC Capital maintained a Buy rating on Pactiv Evergreen (PTVE – Research Report), with a price target of $13.00.The …

businessinsider.com

$0.36
OFF

Pactiv Evergreen’s Q3 2024 Financial Performance And Outlook

1 week from now

However, it achieved an adjusted EPS of $0.36, reflecting strategic financial adjustments. Looking ahead, Pactiv Evergreen is poised for growth, focusing on innovation and expanding its market …

tipranks.com

FAQs about Pactiv Evergreen’s Strategic Transition: Hold Rating Amid … Coupon?

Is Pactiv Evergreen (Pactiv) a good stock to buy?

According to analysts, Pactiv Evergreen is a buy stock. The company has a consensus rating of Buy, based on 3 buy ratings, 3 hold ratings, and no sell ratings. The average rating score is 2.50. The consensus price target is $11.86, which represents a forecasted upside of 55.0% from its current price of $7.65. The stock's current price is from Pactiv Evergreen. ...

Will Pactiv evergreen (PTVE) go public?

Learn More » Pactiv Evergreen (NASDAQ: PTVE) has only been a publicly traded business since the fall of 2020, as the pandemic provided an excellent window of opportunity for the business to go public. Initially, a $15 stock, shares have been trading in a $7-$15 range in more recent times, now trading right in the middle of that. ...

Should you buy Viswanathan (Pactiv evergreen)?

According to TipRanks, Viswanathan has an average return of 0.9% and a 54.34% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Pactiv Evergreen with a $13.30 average price target. ...

How much profit does Pactiv Evergreen make?

Pactiv Evergreen (NASDAQ:PTVE) generates $318 million in net income (profit) each year. ...

Is Pactiv Evergreen (PTVE) a good dividend stock?

Pactiv Evergreen (NASDAQ:PTVE) pays an annual dividend of $0.40 per share and currently has a dividend yield of 4.75%, making it a leading dividend payer with a dividend yield higher than 75% of all dividend-paying stocks. The dividend payout ratio is 22.60%, which is at a healthy, sustainable level, below 75%. ...

Who owns Pactiv evergreen stock?

Top institutional shareholders of Pactiv Evergreen include American Century Companies Inc. (2.99%), Morgan Stanley (1.94%), EVR Research LP (0.87%), Medina Value Partners LLC (0.57%), and Geode Capital Management LLC (0.52%), as well as Charles Schwab Investment Management Inc. (0.48%). ...